Mauve Group shines with a Bronze accolade for the ‘Best Employer of Record Provider’ at the HRM Asia Awards
Mauve Group is awarded Bronze in the ‘Best Employer of Record Service Provider’ category at the HRM Asia Readers’ Choice Awards.Mauve is proud to gain recognition in Asia’s biggest awards for HR solutions. SINGAPORE, Nov. 6, 2023 /PRNewswire/ — Mauve Group announces it
PillWork’s Upcoming Launch and its Landmark Partnership with Precision Nutrition Association
SEOUL, South Korea, Nov. 5, 2023 /PRNewswire/ — With much anticipation surrounding its impending release, PillWork officially announces its launch scheduled for the end of 2023. An integral part of this excitement is the company’s crucial alliance with the esteemed Precision Nutrition A
IUIGA Embarks on a New Chapter in China: Unveiling Innovative Products for the Discerning Consumer
SINGAPORE, Nov. 6, 2023 /PRNewswire/ — IUIGA, Singapore’s leading lifestyle brand, is thrilled to announce its expansion into China, marking a significant milestone in the company’s journey. With a rich history of serving over one million households in Singapore, Jakarta, and Hong
BS2 launches solution that allows international payments and receipts in real time at a more attractive cost
– Tool, which works 24×7, focuses on international remittance companies and should also reach e-commerce and digital wallets SÃO PAULO, Nov. 6, 2023 /PRNewswire/ — BS2, the first Brazilian digital bank (banco digital brasileiro) specialized in companies, launches a unique solutio
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data
SHENZHEN, China, Nov. 6, 2023 /PRNewswire/ — Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a
The World’s First “Recombinant Anthrax Vaccine”: GC Biopharma applies for MFDS Approval
YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ — GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of “GC1109”, an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry o
Board games market size to grow by USD 3.02 billion from 2021 to 2026 | The rapid improvements in content and gameplay are driving the market’s growth – Technavio
NEW YORK, Nov. 5, 2023 /PRNewswire/ — The global board games market size is estimated to increase by USD 3.02 billion from 2021 to 2026. The market’s growth momentum will accelerate at a CAGR of 7.31% during the forecast period. The rapid improvements in content and gameplay are drivin
InterBEE 2023: TVU Networks to Showcase Transformative Advancements in 5G Cellular Transmission and Native 4K Support Cloud Production Ecosystem
The company will showcase its integrated TVU solutions portfolio, including the latest ONE 5G cellular 4K/REMI transmitter and native 4K support across its entire live cloud video production ecosystem. CUPERTINO, Calif., Nov. 6, 2023 /PRNewswire/ — TVU Networks, a pioneer in cloud-based workfl
Indonesian, Australian firms team up on zero-emission steel
JAKARTA, Indonesia and PERTH, Australia, Nov. 6, 2023 /PRNewswire/ — Leading private Indonesian steelmaker PT Gunung Raja Paksi Tbk (GRP), a member of Gunung Steel Group, is working towards a greener, more inclusive future, with a plan to reduce carbon emissions from the steel industry by repl
Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, Nov. 5, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, op
